The EAHP Board, elected for three-year terms, oversees the association’s activities. Comprising directors responsible for core functions, it meets regularly to implement strategic goals. Supported by EAHP staff, the Board controls finances, coordinates congress organization, and ensures compliance with statutes and codes of conduct.
Statement 6.4
“Hospital pharmacists should actively engage in and publish research, particularly on hospital pharmacy practice. Research methods should be part of undergraduate and postgraduate training programmes for hospital pharmacists.”
What does it mean for patients? Patients can rely on the expertise of hospital pharmacists in optimising processes in the hospital in order to achieve the safest and best use of medicines. This should be based on research, which could be provided by hospital pharmacists, as part of the healthcare team
What does it mean for healthcare professionals? Doctors and nurses have a lot to benefit from the expertise of a hospital pharmacist in developing new methods and systems to optimise medication processes. This process should be based on scientific research and hospital pharmacists should be proactive in this field.
What does it mean for Hospital Pharmacists? Hospital pharmacists must be actively engaged in research by developing, implementing and assessing new methods, systems and services to improve safe, effective, appropriate and cost-effective use of medicines
The Uppsalla University Hospital is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
The Hospital Gregorio Marañon is SILCC Host providing training on this Statement. Please learn more about the SILCC programme here.
- SESAME Quiz: a playful online questionnaire to assess patients’ knowledge about Sjogren’s syndrome
- EAHP Policy Statement on Antimicrobial Resistance
- EAHP Survey Report 2015
- EAHP Statements Survey 2015-S.6.4 "The pharmacists in our hospitals routinely publish hospital pharmacy practice research"
- EAHP Statements Survey 2015-S.6.4.1 "Have you or your pharmacists engaged in development of local/national/guidelienes?
- Ease of access to intravenous drug compatibility information for clinical practitioners
- GPI: NEW WEB 2.0. TECHNOLOGIES FOR ANTIDOTE CONSULTATIONS: ACTIVITY AND REACH OF AN APPLICATION FOR MOBILE DEVICES
- GPI: eLearning Environment for Ensuring the Competence in Pharmacotherapy
- GPI:INTRODUCTION OF A PATIENT- CENTRED CLINICAL PHARMACY TRAINING SCHEME IN A LARGE UNIVERSITY HOSPITAL PHARMACY
- GPI: DEVELOPMENT OF AN INTERACTIVE PLATFORM FOR PROVINCE CLINICAL PHARMACEUTICS WHO ARE IN CHARGE OF THE TREATMENT OF HEPATITIS C INFECTED PATIENTS
- EAHP Brochure